Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
1.790
+0.125 (7.51%)
Sep 5, 2025, 4:00 PM - Market closed

Traws Pharma Statistics

Total Valuation

Traws Pharma has a market cap or net worth of $12.64 million. The enterprise value is -$1.00 million.

Market Cap12.64M
Enterprise Value -1.00M

Important Dates

The last earnings date was Thursday, August 14, 2025, before market open.

Earnings Date Aug 14, 2025
Ex-Dividend Date n/a

Share Statistics

Traws Pharma has 7.06 million shares outstanding. The number of shares has increased by 439.67% in one year.

Current Share Class 7.06M
Shares Outstanding 7.06M
Shares Change (YoY) +439.67%
Shares Change (QoQ) -19.32%
Owned by Insiders (%) 5.19%
Owned by Institutions (%) 9.31%
Float 6.03M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 2.74
Forward PS 98.69
PB Ratio 1.42
P/TBV Ratio 1.46
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.09

Current Ratio 2.09
Quick Ratio 1.96
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -248.20% and return on invested capital (ROIC) is -176.40%.

Return on Equity (ROE) -248.20%
Return on Assets (ROA) -73.84%
Return on Invested Capital (ROIC) -176.40%
Return on Capital Employed (ROCE) -245.05%
Revenue Per Employee $414,714
Profits Per Employee -$728,286
Employee Count7
Asset Turnover 0.17
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -80.39% in the last 52 weeks. The beta is 1.52, so Traws Pharma's price volatility has been higher than the market average.

Beta (5Y) 1.52
52-Week Price Change -80.39%
50-Day Moving Average 1.52
200-Day Moving Average 3.35
Relative Strength Index (RSI) 70.38
Average Volume (20 Days) 160,520

Short Selling Information

The latest short interest is 162,903, so 2.31% of the outstanding shares have been sold short.

Short Interest 162,903
Short Previous Month 96,639
Short % of Shares Out 2.31%
Short % of Float 2.70%
Short Ratio (days to cover) 1.29

Income Statement

In the last 12 months, Traws Pharma had revenue of $2.90 million and -$5.10 million in losses. Loss per share was -$1.07.

Revenue2.90M
Gross Profit 2.90M
Operating Income -20.27M
Pretax Income -18.16M
Net Income -5.10M
EBITDA -20.26M
EBIT -20.27M
Loss Per Share -$1.07
Full Income Statement

Balance Sheet

The company has $13.08 million in cash and n/a in debt, giving a net cash position of $13.08 million or $1.85 per share.

Cash & Cash Equivalents 13.08M
Total Debt n/a
Net Cash 13.08M
Net Cash Per Share $1.85
Equity (Book Value) 8.26M
Book Value Per Share 1.17
Working Capital 8.02M
Full Balance Sheet

Cash Flow

Operating Cash Flow -26.93M
Capital Expenditures n/a
Free Cash Flow -26.93M
FCF Per Share -$3.81
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -698.11%
Pretax Margin -613.92%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Traws Pharma does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -439.67%
Shareholder Yield -439.67%
Earnings Yield -42.20%
FCF Yield -222.96%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on September 23, 2024. It was a reverse split with a ratio of 1:25.

Last Split Date Sep 23, 2024
Split Type Reverse
Split Ratio 1:25

Scores

Traws Pharma has an Altman Z-Score of -58.71 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -58.71
Piotroski F-Score 2